LIFECORE BIOMEDICAL, INC. DE [LFCR] has reported fiscal Q3 loss of $15.50 million.
On a per-share basis, the DE based company said its diluted earnings are $0.51.
The Pharmaceutical Preparations firm posted revenue of $27.60 million in this period.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.